Algo version: 0.98b
BEAM is listed at the NASDAQ Exchange
BEAM [BEAM]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is BEAM stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Beam Therapeutics Inc pays dividends. Last time was Monday 3rd of March 2014 where the investors holding the stock on Tuesday 4th of February 2014 were paid $0.22500 per share. Over the last 10 times between 2011 and 2014, Beam Therapeutics Inc has paid $2.155 with an average of $0.22 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Beam Therapeutics Inc 10 years ago, but if you had invested on Thursday 6th of February 2020 when the price was $18.75, you would have made a profit of $4.56 per share or 24.32%

Yes, the average daily trading liquidity for Beam Therapeutics Inc is $30.81 million. You should therefore be able to get in and out of your positions relatively fast.

Beam Therapeutics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Beam Therapeutics Inc to be high [0.85 out of 1]